Roche Holding AG (RHHBF)

Healthcare · Drug Manufacturers - General · OTC · CH

Company news

wsj.com · 13h ago

Roche Backs Full-Year View as First-Half Sales Rise

reuters.com · 13h ago

Roche confirms full year targets as first-half sales fall

zacks.com · 8d ago

RHHBY's Gazyva Gets FDA Priority Review for Label Expansion

marketbeat.com · 15d ago

The Market Just Got Shaken—These 3 ETFs May Come Out Stronger

zacks.com · 20d ago

Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug

wsj.com · 22d ago

Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial

zacks.com · 23d ago

Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease

reuters.com · 24d ago

Roche launches Axelios gene sequencer in a bid to loosen Illumina's grip

zacks.com · 30d ago

EXEL Down on Colorectal Cancer Study Data on Zanzalintinib

youtube.com · 35d ago

U.S.-Iran deal will stick despite being a ‘bad, bad deal', says David Roche

zacks.com · 35d ago

FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL

reuters.com · 36d ago

FDA approves first generic version of Roche's flu drug

zacks.com · 38d ago

JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study

zacks.com · 42d ago

Roche's Tecentriq Plus Chemo Gets FDA Priority Tag for Colon Cancer

seekingalpha.com · 42d ago

Nurix Therapeutics Deal With Roche Is Worth Betting On

seekingalpha.com · 43d ago

Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must Know

reuters.com · 44d ago

Roche sticks to German investment after Eli Lilly cuts

seekingalpha.com · 45d ago

Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript

reuters.com · 45d ago

Roche enters $2 billion cancer drug agreement with Nurix Therapeutics

wsj.com · 46d ago

Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics

Market news & ticker search · RSS for RHHBF